Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Delayed-Action Preparations | 9 | 1999 | 120 | 0.560 |
Why?
|
| Hydrogen-Ion Concentration | 21 | 1998 | 618 | 0.370 |
Why?
|
| Pharmacokinetics | 3 | 1996 | 14 | 0.350 |
Why?
|
| Kinetics | 35 | 1999 | 1047 | 0.320 |
Why?
|
| Cephalosporins | 2 | 1998 | 59 | 0.310 |
Why?
|
| Ceftazidime | 2 | 1998 | 12 | 0.280 |
Why?
|
| Cytarabine | 10 | 1984 | 44 | 0.280 |
Why?
|
| Computer Simulation | 4 | 1999 | 706 | 0.230 |
Why?
|
| Drug Stability | 15 | 1998 | 71 | 0.220 |
Why?
|
| Pharmaceutical Preparations | 7 | 1985 | 101 | 0.220 |
Why?
|
| Dosage Forms | 3 | 1987 | 20 | 0.210 |
Why?
|
| Hydrolysis | 12 | 1998 | 144 | 0.210 |
Why?
|
| Temperature | 7 | 1998 | 341 | 0.200 |
Why?
|
| Buffers | 11 | 1998 | 31 | 0.190 |
Why?
|
| Catalysis | 8 | 1998 | 123 | 0.180 |
Why?
|
| Ancitabine | 3 | 1984 | 3 | 0.180 |
Why?
|
| Models, Biological | 8 | 1999 | 981 | 0.160 |
Why?
|
| Solutions | 5 | 1998 | 115 | 0.160 |
Why?
|
| Arginine | 1 | 1998 | 102 | 0.160 |
Why?
|
| Prodrugs | 2 | 1988 | 54 | 0.150 |
Why?
|
| Models, Theoretical | 5 | 1998 | 384 | 0.150 |
Why?
|
| Nitrophenols | 2 | 1985 | 14 | 0.120 |
Why?
|
| Cefuroxime | 1 | 1994 | 3 | 0.120 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 1993 | 12 | 0.120 |
Why?
|
| Administration, Oral | 5 | 1996 | 411 | 0.110 |
Why?
|
| Drug Delivery Systems | 1 | 1995 | 236 | 0.110 |
Why?
|
| Mathematics | 8 | 1995 | 83 | 0.100 |
Why?
|
| Half-Life | 5 | 1996 | 96 | 0.100 |
Why?
|
| Spectrophotometry, Ultraviolet | 7 | 1994 | 79 | 0.100 |
Why?
|
| Ampicillin | 3 | 1988 | 17 | 0.100 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 1995 | 381 | 0.100 |
Why?
|
| Cytidine | 2 | 1989 | 2 | 0.090 |
Why?
|
| Phenytoin | 1 | 1991 | 27 | 0.090 |
Why?
|
| Theophylline | 2 | 1987 | 22 | 0.090 |
Why?
|
| Hydroxamic Acids | 4 | 1972 | 84 | 0.090 |
Why?
|
| Chromatography, Thin Layer | 6 | 1985 | 52 | 0.090 |
Why?
|
| Chemical Phenomena | 11 | 1988 | 62 | 0.080 |
Why?
|
| Coffee | 1 | 1988 | 18 | 0.080 |
Why?
|
| Drug Storage | 1 | 1988 | 16 | 0.080 |
Why?
|
| Drinking | 1 | 1988 | 35 | 0.080 |
Why?
|
| Biotransformation | 4 | 1998 | 69 | 0.080 |
Why?
|
| Talampicillin | 1 | 1988 | 1 | 0.080 |
Why?
|
| Caffeine | 1 | 1988 | 81 | 0.080 |
Why?
|
| Eating | 1 | 1988 | 119 | 0.080 |
Why?
|
| Liposomes | 2 | 1985 | 107 | 0.070 |
Why?
|
| Captopril | 1 | 1987 | 22 | 0.070 |
Why?
|
| Chemistry, Pharmaceutical | 7 | 1984 | 35 | 0.070 |
Why?
|
| Colorimetry | 5 | 1980 | 22 | 0.070 |
Why?
|
| Solubility | 3 | 1998 | 134 | 0.060 |
Why?
|
| Oxygen | 1 | 1987 | 386 | 0.060 |
Why?
|
| Alkalies | 1 | 1984 | 6 | 0.060 |
Why?
|
| Models, Chemical | 3 | 1996 | 155 | 0.060 |
Why?
|
| Intestinal Absorption | 3 | 1999 | 41 | 0.060 |
Why?
|
| Nucleosides | 3 | 1973 | 9 | 0.060 |
Why?
|
| Indomethacin | 1 | 1982 | 107 | 0.050 |
Why?
|
| Absorption | 4 | 1991 | 49 | 0.050 |
Why?
|
| Barbiturates | 1 | 1981 | 3 | 0.050 |
Why?
|
| Cytosine | 2 | 1972 | 12 | 0.050 |
Why?
|
| Chemistry | 9 | 1974 | 45 | 0.050 |
Why?
|
| Biological Availability | 3 | 1988 | 79 | 0.050 |
Why?
|
| Regression Analysis | 3 | 1999 | 737 | 0.050 |
Why?
|
| Pyrrolizidine Alkaloids | 1 | 1980 | 5 | 0.050 |
Why?
|
| Acetates | 2 | 1972 | 74 | 0.050 |
Why?
|
| Cyclic N-Oxides | 1 | 1980 | 17 | 0.040 |
Why?
|
| Injections, Intravenous | 4 | 1984 | 215 | 0.040 |
Why?
|
| Drug Implants | 2 | 1976 | 19 | 0.040 |
Why?
|
| Time Factors | 7 | 1995 | 4655 | 0.040 |
Why?
|
| Hydrochloric Acid | 3 | 1984 | 19 | 0.040 |
Why?
|
| Adsorption | 1 | 1999 | 225 | 0.040 |
Why?
|
| Drug Interactions | 1 | 1998 | 289 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 4 | 1973 | 1026 | 0.040 |
Why?
|
| Molecular Structure | 1 | 1998 | 397 | 0.040 |
Why?
|
| Chemistry, Physical | 2 | 1988 | 21 | 0.030 |
Why?
|
| Naltrexone | 2 | 1976 | 195 | 0.030 |
Why?
|
| Substance-Related Disorders | 2 | 1976 | 1242 | 0.030 |
Why?
|
| Area Under Curve | 1 | 1996 | 238 | 0.030 |
Why?
|
| Pyridines | 1 | 1998 | 261 | 0.030 |
Why?
|
| Imides | 2 | 1966 | 2 | 0.030 |
Why?
|
| Azacitidine | 1 | 1975 | 20 | 0.030 |
Why?
|
| Computers | 2 | 1991 | 63 | 0.030 |
Why?
|
| Naloxone | 1 | 1975 | 56 | 0.030 |
Why?
|
| Suspensions | 2 | 1985 | 11 | 0.030 |
Why?
|
| Cholinesterases | 1 | 1974 | 1 | 0.030 |
Why?
|
| Narcotic Antagonists | 1 | 1976 | 184 | 0.030 |
Why?
|
| Deamination | 2 | 1989 | 4 | 0.030 |
Why?
|
| Iron | 3 | 1972 | 197 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 1993 | 55 | 0.030 |
Why?
|
| Spectrophotometry | 5 | 1972 | 54 | 0.030 |
Why?
|
| Humans | 12 | 1996 | 68618 | 0.030 |
Why?
|
| Algorithms | 1 | 1999 | 1196 | 0.030 |
Why?
|
| Digoxin | 1 | 1973 | 24 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 1974 | 205 | 0.030 |
Why?
|
| Pyrrolidines | 2 | 1969 | 45 | 0.030 |
Why?
|
| Uracil | 2 | 1975 | 18 | 0.030 |
Why?
|
| Hydroxides | 1 | 1972 | 5 | 0.030 |
Why?
|
| Adult | 4 | 1996 | 21403 | 0.020 |
Why?
|
| Deoxyribose | 1 | 1989 | 3 | 0.020 |
Why?
|
| Cyclohexanes | 1 | 1969 | 10 | 0.020 |
Why?
|
| Cycloheximide | 1 | 1969 | 50 | 0.020 |
Why?
|
| Structure-Activity Relationship | 4 | 1974 | 420 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 1991 | 567 | 0.020 |
Why?
|
| Pyridones | 1 | 1969 | 40 | 0.020 |
Why?
|
| Ultraviolet Rays | 4 | 1972 | 130 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 1991 | 652 | 0.020 |
Why?
|
| Biopharmaceutics | 2 | 1981 | 5 | 0.020 |
Why?
|
| Animals | 7 | 1985 | 20881 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 1988 | 334 | 0.020 |
Why?
|
| Methods | 3 | 1974 | 156 | 0.020 |
Why?
|
| Cyclodextrins | 1 | 1987 | 2 | 0.020 |
Why?
|
| Partial Pressure | 1 | 1987 | 19 | 0.020 |
Why?
|
| Dimyristoylphosphatidylcholine | 1 | 1985 | 4 | 0.020 |
Why?
|
| Cetrimonium Compounds | 1 | 1985 | 4 | 0.020 |
Why?
|
| Calcium Carbonate | 1 | 1965 | 7 | 0.020 |
Why?
|
| Phosphatidylcholines | 1 | 1985 | 38 | 0.020 |
Why?
|
| Haplorhini | 2 | 1976 | 44 | 0.020 |
Why?
|
| Copper | 1 | 1987 | 149 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 1987 | 567 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 1966 | 108 | 0.020 |
Why?
|
| Particle Size | 1 | 1985 | 201 | 0.020 |
Why?
|
| Antibiotics, Antitubercular | 1 | 1965 | 18 | 0.020 |
Why?
|
| Enzymes | 1 | 1985 | 25 | 0.020 |
Why?
|
| Species Specificity | 2 | 1976 | 303 | 0.020 |
Why?
|
| Amines | 1 | 1985 | 98 | 0.020 |
Why?
|
| Sodium Hydroxide | 1 | 1984 | 5 | 0.020 |
Why?
|
| Atmosphere | 1 | 1984 | 6 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1985 | 167 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1985 | 137 | 0.010 |
Why?
|
| Dogs | 2 | 1976 | 490 | 0.010 |
Why?
|
| Blood Proteins | 2 | 1975 | 94 | 0.010 |
Why?
|
| Research | 1 | 1965 | 214 | 0.010 |
Why?
|
| Rabbits | 1 | 1984 | 509 | 0.010 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 1985 | 148 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1984 | 765 | 0.010 |
Why?
|
| Densitometry | 1 | 1981 | 15 | 0.010 |
Why?
|
| Viscosity | 1 | 1981 | 72 | 0.010 |
Why?
|
| Diffusion | 1 | 1981 | 90 | 0.010 |
Why?
|
| Thermodynamics | 1 | 1981 | 162 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1981 | 44 | 0.010 |
Why?
|
| Amoxicillin | 1 | 1980 | 10 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 1965 | 1070 | 0.010 |
Why?
|
| Child | 1 | 1987 | 6405 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1975 | 124 | 0.010 |
Why?
|
| Aminohydrolases | 1 | 1974 | 1 | 0.010 |
Why?
|
| Nucleoside Deaminases | 1 | 1974 | 3 | 0.010 |
Why?
|
| Morphine | 1 | 1975 | 76 | 0.010 |
Why?
|
| Apnea | 1 | 1974 | 16 | 0.010 |
Why?
|
| Metabolism, Inborn Errors | 1 | 1974 | 19 | 0.010 |
Why?
|
| Succinylcholine | 1 | 1974 | 15 | 0.010 |
Why?
|
| Reaction Time | 1 | 1975 | 170 | 0.010 |
Why?
|
| Albumins | 1 | 1974 | 72 | 0.010 |
Why?
|
| Cytosine Nucleotides | 1 | 1973 | 2 | 0.010 |
Why?
|
| Lincomycin | 1 | 1973 | 4 | 0.010 |
Why?
|
| Cloxacillin | 1 | 1973 | 2 | 0.010 |
Why?
|
| Clindamycin | 1 | 1973 | 25 | 0.010 |
Why?
|
| Erythromycin | 1 | 1973 | 13 | 0.010 |
Why?
|
| Computers, Analog | 1 | 1973 | 1 | 0.010 |
Why?
|
| Pharmacology | 1 | 1973 | 9 | 0.010 |
Why?
|
| Tetracycline | 1 | 1973 | 29 | 0.010 |
Why?
|
| Penicillins | 1 | 1973 | 32 | 0.010 |
Why?
|
| Methylation | 1 | 1972 | 56 | 0.010 |
Why?
|
| Models, Structural | 1 | 1972 | 22 | 0.010 |
Why?
|
| Deuterium | 1 | 1972 | 10 | 0.010 |
Why?
|
| Hydroxylamines | 1 | 1972 | 20 | 0.010 |
Why?
|
| Chelating Agents | 1 | 1972 | 47 | 0.010 |
Why?
|
| Protein Binding | 1 | 1975 | 1027 | 0.010 |
Why?
|
| Kidney | 2 | 1974 | 945 | 0.010 |
Why?
|
| Heart Rate | 1 | 1973 | 568 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1974 | 1745 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 1973 | 365 | 0.010 |
Why?
|
| Esters | 1 | 1969 | 22 | 0.010 |
Why?
|
| Research Design | 1 | 1973 | 729 | 0.010 |
Why?
|
| Sulfites | 1 | 1967 | 7 | 0.000 |
Why?
|
| Hydrogen | 1 | 1967 | 35 | 0.000 |
Why?
|
| Sodium | 1 | 1967 | 161 | 0.000 |
Why?
|
| Rats | 1 | 1975 | 5300 | 0.000 |
Why?
|
| Carbon Dioxide | 1 | 1965 | 78 | 0.000 |
Why?
|
| Mice | 1 | 1975 | 8474 | 0.000 |
Why?
|
| Male | 1 | 1984 | 37321 | 0.000 |
Why?
|
| Cycloheptanes | 1 | 1980 | 1 | 0.000 |
Why?
|
| Biodegradation, Environmental | 1 | 1980 | 92 | 0.000 |
Why?
|
| Ketones | 1 | 1978 | 24 | 0.000 |
Why?
|
| Swine | 1 | 1974 | 672 | 0.000 |
Why?
|
| Female | 1 | 1974 | 38074 | 0.000 |
Why?
|